Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
Clinical trial NCT04190056 · TERMINATED
Trial details
- NCT number
- NCT04190056
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2023-06-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.